Your email has been successfully added to our mailing list.

×
-0.0023472400999468 -0.00295297948057838 -0.00128719618384181 0.000832891648368393 0.000227152267736815 -0.00249867494510475 0.00870750359657762 -0.00174150071931544
Stock impact report

BRIEF-Incyte's Mid-stage Geometry Mono-1 Trial Of Investigational Medicine Capmatinib Shows Positive Results [Reuters]

Incyte Corporation (INCY) 
Last incyte corporation earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: incyte.com/ir/investor-overview.aspx
Company Research Source: Reuters
BRIEF-Incyte's Mid-stage Geometry Mono-1 Trial Of Investigational Medicine Capmatinib Shows Positive Results | Reuters 1 Min Read Oct 19 (Reuters) - Incyte Corp: * PHASE 2 GEOMETRY MONO-1 TRIAL OF INVESTIGATIONAL MEDICINE CAPMATINIB SHOWS POSITIVE RESULTS IN PATIENTS WITH MET-MUTATED ADVANCED NSCLC * ADVERSE EVENTS (AES) WERE CONSISTENT WITH PREVIOUSLY REPORTED DATA AND NO NEW SAFETY SIGNALS WERE OBSERVED IN STUDY * CLINICAL FINDINGS FROM ONGOING STUDY INDICATE SAFETY PROFILE WAS CONSISTENT WITH PREVIOUSLY REPORTED DATA RESULTS * NOVARTIS HAS EXCLUSIVE DEVELOPMENT & COMMERCIALIZATION WORLDWIDE RIGHTS TO CAPMATINIB Source text for Eikon: Further company coverage: All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. © 2018 Reuters. All Rights Reserved. BRIEF-Incyte's Mid-stage Geometry Mono-1 Trial Of Investigational Medicine Capmatinib Shows Positive Results Oct 19 (Reuters) - Incyte Corp: * PHASE 2 GEOMETRY MONO-1 TRIAL OF INVESTIG Show less Read more
Impact Snapshot
Event Time:
INCY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for INCY alerts
Opt-in for
INCY alerts

from News Quantified
Opt-in for
INCY alerts

from News Quantified